BACKGROUND:Constraint-induced movement therapy (CIMT) has received considerable attention as an intervention to enhance motor recovery and cortical reorganization after stroke. OBJECTIVE: The present study represents the first multi-center effort to measure cortical reorganization induced by CIMT in subjects who are in the subacute stage of recovery. METHODS: A total of 30 stroke subjects in the subacute phase (>3 and <9 months poststroke) were recruited and randomized into experimental (receiving CIMT immediately after baseline evaluation) and control (receiving CIMT after 4 months) groups. Each subject was evaluated using transcranial magnetic stimulation (TMS) at baseline, 2 weeks after baseline, and at 4-month follow-up (ie, after CIMT in the experimental groups and before CIMT in the control groups). The primary clinical outcome measure was the Wolf Motor Function Test. RESULTS: Both experimental and control groups demonstrated improved hand motor function 2 weeks after baseline. The experimental group showed significantly greater improvement in grip force after the intervention and at follow-up (P = .049). After adjusting for the baseline measures, the experimental group had an increase in the TMS motor map area compared with the control group over a 4-month period; this increase was of borderline significance (P = .053). CONCLUSIONS: Among subjects who had a stroke within the previous 3 to 9 months, CIMT produced statistically significant and clinically relevant improvements in arm motor function that persisted for at least 4 months. The corresponding enlargement of TMS motor maps, similar to that found in earlier studies of chronic stroke subjects, appears to play an important role in CIMT-dependent plasticity.
RCT Entities:
BACKGROUND: Constraint-induced movement therapy (CIMT) has received considerable attention as an intervention to enhance motor recovery and cortical reorganization after stroke. OBJECTIVE: The present study represents the first multi-center effort to measure cortical reorganization induced by CIMT in subjects who are in the subacute stage of recovery. METHODS: A total of 30 stroke subjects in the subacute phase (>3 and <9 months poststroke) were recruited and randomized into experimental (receiving CIMT immediately after baseline evaluation) and control (receiving CIMT after 4 months) groups. Each subject was evaluated using transcranial magnetic stimulation (TMS) at baseline, 2 weeks after baseline, and at 4-month follow-up (ie, after CIMT in the experimental groups and before CIMT in the control groups). The primary clinical outcome measure was the Wolf Motor Function Test. RESULTS: Both experimental and control groups demonstrated improved hand motor function 2 weeks after baseline. The experimental group showed significantly greater improvement in grip force after the intervention and at follow-up (P = .049). After adjusting for the baseline measures, the experimental group had an increase in the TMS motor map area compared with the control group over a 4-month period; this increase was of borderline significance (P = .053). CONCLUSIONS: Among subjects who had a stroke within the previous 3 to 9 months, CIMT produced statistically significant and clinically relevant improvements in arm motor function that persisted for at least 4 months. The corresponding enlargement of TMS motor maps, similar to that found in earlier studies of chronic stroke subjects, appears to play an important role in CIMT-dependent plasticity.
Authors: Farsin Hamzei; Joachim Liepert; Christian Dettmers; Cornelius Weiller; Michel Rijntjes Journal: Neuroimage Date: 2006-03-03 Impact factor: 6.556
Authors: P M Rossini; A T Barker; A Berardelli; M D Caramia; G Caruso; R Q Cracco; M R Dimitrijević; M Hallett; Y Katayama; C H Lücking Journal: Electroencephalogr Clin Neurophysiol Date: 1994-08
Authors: P M Rossini; C Caltagirone; A Castriota-Scanderbeg; P Cicinelli; C Del Gratta; M Demartin; V Pizzella; R Traversa; G L Romani Journal: Neuroreport Date: 1998-06-22 Impact factor: 1.837
Authors: Steven L Wolf; Paul A Thompson; David M Morris; Dorian K Rose; Carolee J Winstein; Edward Taub; Carol Giuliani; Sonya L Pearson Journal: Neurorehabil Neural Repair Date: 2005-09 Impact factor: 3.919
Authors: Steven L Wolf; Carolee J Winstein; J Philip Miller; Edward Taub; Gitendra Uswatte; David Morris; Carol Giuliani; Kathye E Light; Deborah Nichols-Larsen Journal: JAMA Date: 2006-11-01 Impact factor: 56.272
Authors: Edward Taub; Gitendra Uswatte; Danna Kay King; David Morris; Jean E Crago; Anjan Chatterjee Journal: Stroke Date: 2006-03-02 Impact factor: 7.914
Authors: David T Pruitt; Ariel N Schmid; Tanya T Danaphongse; Kate E Flanagan; Robert A Morrison; Michael P Kilgard; Robert L Rennaker; Seth A Hays Journal: Behav Brain Res Date: 2016-07-05 Impact factor: 3.332
Authors: A Lex E Q van Delden; C Lieke E Peper; Jaap Harlaar; Andreas Daffertshofer; Nienke I Zijp; Kirsten Nienhuys; Peter Koppe; Gert Kwakkel; Peter J Beek Journal: BMC Neurol Date: 2009-11-06 Impact factor: 2.474